You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博濟醫藥(300404.SZ):控股股東王廷春擬4181萬元認繳投資物明創新3700萬財產份額
格隆匯 04-13 20:31

格隆匯4月13日丨博濟醫藥(300404.SZ)公佈,為了順利推進新藥產業投資基金後續的相關工作,2020年4月13日,公司第三屆董事會第二十二次董事會審議通過了《關於控股股東參與新藥產業投資基金暨關聯交易的議案》,控股股東王廷春擬以人民幣出資4181萬元認繳投資深圳市物明創新新藥產業投資合夥企業(有限合夥)(“物明創新”)中3700萬的財產份額。

物明創新的有限合夥人之一西藏博濟投資管理有限公司(“博濟投資”)為公司的全資子公司,王廷春為公司的控股股東、實際控制人、董事長、總經理。按照《深圳證券交易所創業板股票上市規則》等相關規定,此次交易構成關聯交易。

王廷春此次參與新藥產業投資基金,意在集中各方優勢資源,更大範圍內尋求對公司有戰略意義的優質目標,把握戰略性投資機會,進一步加快公司的產業佈局,提高公司投資效率,有利於為公司未來發展儲備潛在優質標的,抓住市場發展機遇,進一步完善公司對全產鏈佈局的戰略定位,該事項對公司短期業績及財務狀況無重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account